{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nPRDM5 is a multifunctional transcription factor essential for extracellular matrix homeostasis and normal ocular development. Mutations in PRDM5 have been causally linked to brittle cornea syndrome and other anterior segment disorders by disrupting the regulation of key extracellular matrix components—particularly fibrillar collagens—which in turn leads to severe corneal thinning, fragility, and other connective tissue abnormalities. Defective PRDM5 function has also been implicated in altered retinal and corneal endothelial cell homeostasis, underscoring its critical role in eye integrity and the broader regulation of connective tissue structures in the anterior segment."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "7"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn addition to its role in tissue integrity, PRDM5 acts as a potent tumor suppressor in various malignancies. It exerts its anti‐proliferative effects through sequence-specific DNA binding, recruitment of chromatin‐modifying complexes, and epigenetic regulation that induce cell cycle arrest and apoptosis. Loss or silencing of PRDM5—often through promoter hypermethylation—correlates with activation of oncogenic pathways such as Wnt and Akt signaling, as well as with enhanced tumor cell proliferation and migration in cancers including those of the breast, ovary, liver, cervix, colon, lung, esophagus, and even gliomas. Its inactivation is frequently associated with poorer clinical outcomes, highlighting a central role in maintaining cellular homeostasis and preventing malignant transformation."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "8", "end_ref": "19"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond its established roles in extracellular matrix regulation and tumor suppression, PRDM5 also influences a variety of other biological processes. It contributes to hematopoiesis through its interaction with transcriptional regulators such as Gfi1, thereby modulating genes involved in blood cell differentiation. Moreover, PRDM5 participates in inflammatory responses by mediating IFN‑γ–induced apoptosis in intestinal epithelial cells, a mechanism implicated in the pathogenesis of conditions like Crohn’s disease. Alterations in PRDM5 gene copy number have further been linked to dysregulation of microRNA expression, underscoring the multifaceted impact of PRDM5 on gene regulatory networks in both normal physiology and disease states."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "20", "end_ref": "22"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Emma M M Burkitt Wright, Helen L Spencer, Sarah B Daly, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Mutations in PRDM5 in brittle cornea syndrome identify a pathway regulating extracellular matrix development and maintenance."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Hum Genet (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.ajhg.2011.05.007"}], "href": "https://doi.org/10.1016/j.ajhg.2011.05.007"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21664999"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21664999"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Shazia Micheal, Sorath Noorani Siddiqui, Saemah Nuzhat Zafar, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Whole exome sequencing identifies a heterozygous missense variant in the PRDM5 gene in a family with Axenfeld-Rieger syndrome."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neurogenetics (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s10048-015-0462-0"}], "href": "https://doi.org/10.1007/s10048-015-0462-0"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26489929"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26489929"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Louise F Porter, Roberto Gallego-Pinazo, Catherine L Keeling, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Bruch's membrane abnormalities in PRDM5-related brittle cornea syndrome."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Orphanet J Rare Dis (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s13023-015-0360-4"}], "href": "https://doi.org/10.1186/s13023-015-0360-4"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26560304"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26560304"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Shazia Micheal, Muhammad Imran Khan, Farrah Islam, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Identification of Mutations in the PRDM5 Gene in Brittle Cornea Syndrome."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cornea (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1097/ICO.0000000000000824"}], "href": "https://doi.org/10.1097/ICO.0000000000000824"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27032025"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27032025"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Kostadin Rolev, Dominic G O'Donovan, Christiana Georgiou, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Identification of Prdm genes in human corneal endothelium."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Exp Eye Res (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.exer.2017.02.009"}], "href": "https://doi.org/10.1016/j.exer.2017.02.009"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28228349"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28228349"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Xun Wang, Xing Liu, Liqin Huang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Mutation Survey of Candidate Genes and Genotype-Phenotype Analysis in 20 Southeastern Chinese Patients with Axenfeld-Rieger Syndrome."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Curr Eye Res (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1080/02713683.2018.1493129"}], "href": "https://doi.org/10.1080/02713683.2018.1493129"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29939776"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29939776"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Louise F Porter, Giorgio G Galli, Sally Williamson, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A role for repressive complexes and H3K9 di-methylation in PRDM5-associated brittle cornea syndrome."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hum Mol Genet (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/hmg/ddv345"}], "href": "https://doi.org/10.1093/hmg/ddv345"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26395458"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26395458"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Qingdong Deng, Shi Huang "}, {"type": "b", "children": [{"type": "t", "text": "PRDM5 is silenced in human cancers and has growth suppressive activities."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/sj.onc.1207615"}], "href": "https://doi.org/10.1038/sj.onc.1207615"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15077163"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15077163"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Yoshiyuki Watanabe, Minoru Toyota, Yutaka Kondo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "PRDM5 identified as a target of epigenetic silencing in colorectal and gastric cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Cancer Res (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/1078-0432.CCR-07-0305"}], "href": "https://doi.org/10.1158/1078-0432.CCR-07-0305"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17699856"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17699856"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Xing-sheng Shu, Hua Geng, Lili Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The epigenetic modifier PRDM5 functions as a tumor suppressor through modulating WNT/β-catenin signaling and is frequently silenced in multiple tumors."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0027346"}], "href": "https://doi.org/10.1371/journal.pone.0027346"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22087297"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22087297"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Shuang-Xiang Tan, Rui-Cheng Hu, Jing-Jing Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Methylation of PRDM2, PRDM5 and PRDM16 genes in lung cancer cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Clin Exp Pathol (2014)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24966940"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24966940"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "G G Galli, H A Multhaupt, M Carrara, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Prdm5 suppresses Apc(Min)-driven intestinal adenomas and regulates monoacylglycerol lipase expression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/onc.2013.283"}], "href": "https://doi.org/10.1038/onc.2013.283"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23873026"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23873026"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Shuang-Xiang Tan, Rui-Cheng Hu, Yong-Li Tan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Promoter methylation-mediated downregulation of PRDM5 contributes to the development of lung squamous cell carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Tumour Biol (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s13277-013-1593-2"}], "href": "https://doi.org/10.1007/s13277-013-1593-2"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24395656"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24395656"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Catherine E Bond, Mark L Bettington, Sally-Ann Pearson, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Methylation and expression of the tumour suppressor, PRDM5, in colorectal cancer and polyp subgroups."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "BMC Cancer (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s12885-015-1011-9"}], "href": "https://doi.org/10.1186/s12885-015-1011-9"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25613750"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25613750"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Hai-Yan Cheng, Xiu-Wei Chen, Li Cheng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "DNA methylation and carcinogenesis of PRDM5 in cervical cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cancer Res Clin Oncol (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00432-010-0840-9"}], "href": "https://doi.org/10.1007/s00432-010-0840-9"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20213097"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20213097"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Xiaolin Wang, Hao Chang, Guangzhong Gao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Silencing of PRDM5 increases cell proliferation and inhibits cell apoptosis in glioma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Neurosci (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1080/00207454.2020.1733563"}], "href": "https://doi.org/10.1080/00207454.2020.1733563"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32083978"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32083978"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Chunyang Zhang, Ziyang Liu, Yinliang Sheng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "PRDM5 suppresses oesophageal squamous carcinoma cells and modulates 14-3-3zeta/Akt signalling pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Exp Pharmacol Physiol (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/1440-1681.13612"}], "href": "https://doi.org/10.1111/1440-1681.13612"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34757658"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34757658"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Yuanyuan Ren, Ye Wang, Lijiao Fang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Deregulation of PRDM5 promotes cell proliferation by regulating JAK/STAT signaling pathway through SOCS1 in human lung adenocarcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Med (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/cam4.5251"}], "href": "https://doi.org/10.1002/cam4.5251"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "36127737"}], "href": "https://pubmed.ncbi.nlm.nih.gov/36127737"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Jing Guo, Qiuxing Yang, Sheng Wei, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Low expression of PRDM5 predicts poor prognosis of esophageal squamous cell carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "BMC Cancer (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s12885-022-09787-8"}], "href": "https://doi.org/10.1186/s12885-022-09787-8"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35799142"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35799142"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Zhijun Duan, Richard E Person, Hu-Hui Lee, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Epigenetic regulation of protein-coding and microRNA genes by the Gfi1-interacting tumor suppressor PRDM5."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell Biol (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1128/MCB.00762-07"}], "href": "https://doi.org/10.1128/MCB.00762-07"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17636019"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17636019"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Han Wu, Liang Wang, Dongmei Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "PRDM5 promotes the apoptosis of epithelial cells induced by IFN-γ during Crohn's disease."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Pathol Res Pract (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.prp.2016.12.004"}], "href": "https://doi.org/10.1016/j.prp.2016.12.004"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28476379"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28476379"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Barbara Marzec-Kotarska, Marek Cybulski, Józef Czesław Kotarski, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Molecular bases of aberrant miR-182 expression in ovarian cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Genes Chromosomes Cancer (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/gcc.22387"}], "href": "https://doi.org/10.1002/gcc.22387"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27295517"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27295517"}]}]}]}